Carafate (Sucralfate) - Indications and Dosage

INDICATIONS AND USAGE

CARAFATE® (sucralfate) is indicated in:

• Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.
• Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.

DOSAGE AND ADMINISTRATION

Active Duodenal Ulcer.    The recommended adult oral dosage for duodenal ulcer is 1 g four times per day on an empty stomach.

Antacids may be prescribed as needed for relief of pain but should not be taken within one-half hour before or after sucralfate.

While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.

Maintenance Therapy:    The recommended adult oral dosage is 1 g twice a day.

HOW SUPPLIED

CARAFATE (sucralfate) 1-g tablets are supplied in bottles of 100 (NDC 58914-171-10), 120 (NDC 58914-171-21), and 500 (NDC 58914-171-50). Light pink, scored, oblong tablets are embossed with CARAFATE on one side and 1712 on the other.

Rx Only

Prescribing Information as of April 2004

Axcan Scandipharm Inc.

22 Inverness Center Parkway

Birmingham, AL 35242

www.axcan.com